Donald Frail
Directeur/Membre du Conseil chez Pandion Operations, Inc.
Profil
Donald Frail is currently the Director at Pandion Operations, Inc. and Senior Advisor at Frazier Management LLC.
Previously, he worked as an Independent Director at Pandion Therapeutics, Inc. from 2019 to 2021.
He also held positions as Chief Scientific Officer-Indications Discovery at Pfizer Inc., Vice President-New Opportunities at AstraZeneca PLC, Vice President, Head-Research & External Science at AbbVie, Inc., and Senior Vice President & Head-Research at Allergan Ltd.
(Ireland).
Frail holds a doctorate degree from McGill University and an undergraduate degree from Stony Brook University.
Postes actifs de Donald Frail
| Sociétés | Poste | Début |
|---|---|---|
Pandion Operations, Inc.
 Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Pandion Operations, Inc. develops drugs for autoimmune, inflammatory, and transplant indications. The company was founded by Anthony J. Coyle, Jo Viney, Alan Crane, and David Sachs in 2017 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 28/01/2020 |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Consultant / Advisor | 01/01/2020 |
Anciens postes connus de Donald Frail
| Sociétés | Poste | Fin |
|---|---|---|
| PANDION THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/04/2021 |
| ALLERGAN PLC | Directeur Technique/Scientifique/R&D | 08/05/2020 |
| PFIZER, INC. | Corporate Officer/Principal | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
| ABBVIE INC. | Corporate Officer/Principal | - |
Formation de Donald Frail
| Stony Brook University | Undergraduate Degree |
| McGill University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ABBVIE INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| PFIZER, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Pandion Therapeutics, Inc.
 Pandion Therapeutics, Inc. BiotechnologyHealth Technology Pandion Therapeutics, Inc. is a clinical stage biopharmaceutical company. It develops Therapeutic Autoimmune reguLatOry proteiN (TALON) drug design and discovery platform, which employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network. The company was founded by Dr. Joanne Viney on September 19, 2016 and is headquartered in Watertown, MA. | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Pandion Operations, Inc.
Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Pandion Operations, Inc. develops drugs for autoimmune, inflammatory, and transplant indications. The company was founded by Anthony J. Coyle, Jo Viney, Alan Crane, and David Sachs in 2017 and is headquartered in Cambridge, MA. | Commercial Services |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Finance |